Ex vivo mass spectrometry-based biodistribution analysis of an antibody-Resiquimod conjugate bearing a protease-cleavable and acid-labile linker.
Bisbal Lopez L, Ravazza D, Bocci M, Zana A, Principi L, Dakhel Plaza S, Galbiati A, Gilardoni E, Scheuermann J, Neri D, Pignataro L, Gennari C, Cazzamalli S, Dal Corso A.
Bisbal Lopez L, et al. Among authors: gennari c.
Front Pharmacol. 2023 Dec 6;14:1320524. doi: 10.3389/fphar.2023.1320524. eCollection 2023.
Front Pharmacol. 2023.
PMID: 38125888
Free PMC article.